PHARMA
First Made-In-China Vaccine Prequalified By WHO
A new vaccine against Japanese encephalitis has been added by the World Health Organization (WHO) to its list of prequalified medicines.
Takeda And New Institute In Early-Stage Drug Discovery Partnership
Takeda will partner the newly formed Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) in early-stage drug discovery.
Boehringer Ingelheim Opens R&D Lab In China
Boehringer Ingelheim has opened a chemicals R&D laboratory Center of Competence in the Zhangjiang High-Tech Park in Shanghai.
PeptiDream & Ipsen To Expand Peptide Drug Collaboration
PeptiDream Inc., and Ipsen have expanded the scope of their collaboration to discover, evaluate, potentially develop and launch therapeutic peptides.
Allergan To License Medytox’s Botox-Like Products
Medytox, Inc. has granted Allergan exclusive licensing rights to certain neurotoxin product candidates currently in development, including a potential liquid-injectable product.
Amgen China R&D Center To Open On ShanghaiTech Campus
Amgen will open a China research and development center at ShanghaiTech University in 2014.
GE Healthcare Life Sciences To Build Biopharma Factory In China
GE Healthcare Life Sciences and biologics manufacturer JHL Biotech today announced that they will build a new biopharmaceutical factory in China.
Luqa Pharma, Stratpharma Extend Collaboration In China
Stratpharma and Luqa Pharma have extended their collaboration past 2020 in the areas of cosmetic dermatology, plastic surgery, burns, wounds and scar management.
MicroConstants China Licenses Liver Cancer Drug From Pertinax Therapeutics
MicroConstants China Inc. has licensed the China rights for a Phase II liver cancer drug candidate, PTX-9908, from Pertinax Therapeutics of Canada.
